# Colchicine for Amyotrophic Lateral Sclerosis

> **NCT03693781** · PHASE2 · COMPLETED · sponsor: **Azienda Ospedaliero-Universitaria di Modena** · enrollment: 54 (actual)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **DRUG:** Colchicine 1 MG Oral Tablet
- **DRUG:** Colchicine 1 MG Oral Tablet
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03693781
- **Lead sponsor:** Azienda Ospedaliero-Universitaria di Modena
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-10
- **Primary completion:** 2022-04-14
- **Final completion:** 2023-01-03
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2023-03-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03693781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03693781, "Colchicine for Amyotrophic Lateral Sclerosis". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT03693781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*